Red Sox pitcher Chris Sale undergoes MRI for sore elbow

Home / MLB JERSEYS / Red Sox pitcher Chris Sale undergoes MRI for sore elbow
Spread the love

Boston Red Sox left-hander Chris Sale has undergone an MRI on Tuesday after experiencing soreness in his elbow following his first live batting practice session.

The Red Sox have already seen the results of the MRI but sent them to Dr. James Andrews for further evaluation, Boston’s chief baseball officer Chaim Bloom said.

Sale, 30, saw Dr. Andrews last August after the seven-time All-Star was shut down for the season with elbow inflammation. Sale had a platelet-rich plasma injection at the time but avoided nfl jerseys for cheap

“Anytime something like this happens, it’s going to make you concerned,” Bloom said. “I also know, in building up when you do hit these milestones, you can get sore. He hasn’t faced hitters in a long time. To speculate too much would be irresponsible. Needless to say, everything has gone so well to this point. This is our first bump in the road. Hopefully, it’s just a bump in the road. You can’t help but have some concern.”2

Sale threw to batters Sunday for the first time since August, doing a full pregame routine with long toss and time in the bullpen and then 15 pitches on the mound.

On Monday morning, he told the team of the soreness in his elbow.

“At a minimum, even if this is fairly benign, we know this is going to set him back to some degree,” Bloom said. “How long? Again, I don’t know yet.”

He last faced hitters on Aug. 13, giving up five runs with 12 strikeouts over 6⅔ innings in a win at Cleveland. He was placed on the injured list and shut down with elbow inflammation, ending his worst season at 6-11 with a 4.40 ERA in 25 starts.

The Red Sox had already said that Sale will start this season on the injured list after he reported to camp with pneumonia.

Last March, the Red Sox signed Sale to a five-year, $145 million contract extension. The new deal starts this season and runs through the 2024 season. Sale will earn $30 million per year from 2020 to 2022 and $27.5 million in ’23 and ’24.